Contact Us

If your question is about a medical condition, then you should consult with a healthcare professional or, in the case of an emergency, call 911 immediately.

Standard business hours for CSL Behring are 8:30 am to 5:00 pm Eastern Time.

  • CSL Behring Headquarters

    Phone: 610-878-4000
    Fax: 610-878-4009
    Location: North America Headquarters
    Address: P.O. Box 61501
    1020 First Avenue
    King of Prussia, PA 19406 USA

  • Consumer Affairs

    For Consumer Information
    Phone: 888-508-6978
    Fax: 610-878-4008

    Medical Affairs

    Phone: 800-504-5434
    Fax: 610-878-4007

  • Adverse Events

    To Report an Adverse Event
    Phone: 610-878-4193
    Phone (After Business
    Hours): 866-915-6958

  • Fields marked with an asterisk (*) are required.
Verification Code

Prior to submitting your information, please review our Privacy Policy.

Important Safety Information

Alpha1-Proteinase Inhibitor (Human), Zemaira® is indicated for chronic augmentation and maintenance therapy for adults with alpha1-proteinase inhibitor (A1-PI) deficiency and emphysema. Clinical data demonstrating the long-term effects of chronic augmentation therapy with Zemaira are not available.

Zemaira may not be appropriate for the following adult individuals as they may experience severe reactions, including anaphylaxis: individuals with a known hypersensitivity and/or history of anaphylaxis or severe systemic reaction to A1-PI products or their components, and individuals with selective IgA deficiencies who have known antibodies against IgA.

In clinical studies, the following treatment-related adverse reactions were reported in 1% of subjects: asthenia (fatigue), injection-site pain, dizziness, headache, paresthesia (tingling), and pruritus (itching).

Zemaira is derived from human plasma. The risk of transmission of infectious agents, including viruses and, theoretically, the Creutzfeldt-Jakob disease (CJD) agent, cannot be completely eliminated.

Please see full prescribing information.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.